Global Fertility Drugs Market to be Driven by Rising Demand for Gonadotropins During the Forecast Period 2022-2027

Expert Market Research’s new report titled “Global Fertility Drugs Market Report and Forecast 2022-2027′, gives an in-depth analysis of the Global Fertility Drugs Market, assessing the market based on its segments such as drug classes, end-users, distribution channels, and major regions. The report tracks the latest industry trends and studies their impact on the overall market. It also assesses market dynamics, covering key demand and price indicators, as well as market analysis based on SWOT and Porter’s Five Forces models.

Get Free Sample Report With TOC:

Key highlights of the report include:

Market Overview (2017-2027)

• Forecast CAGR (2022-2027): 6.20%

The infertility drug market is driven by the growing demand for gonadotropins. This can be attributed to their ability to increase the chances of pregnancy. As gonadotropins do not cause severe side effects as compared to other drug classes, women are increasingly preferring them to stimulate ovaries for follicle production, thus increasing the market. Women in Europe and North America are increasingly bearing children at older ages, increasing the risk of infertility and fueling the market for infertility drugs. Additionally, increasing accessibility to innovative infertility drugs through the robust healthcare infrastructure is giving impetus to the growth of the market.

Industry definition and major segments

Fertility drugs refer to drugs used in the treatment of infertility problems in both men and women. They are usually prescribed by medical professionals to stimulate ovulation in women and to enable the production of healthy sperm in men. They are integral to increasing the chances of pregnancy.

Read Full Report with TOC:

On the basis of Drug Class, the market is split into:

• Gonadotropins
• Aromatase inhibitors
• Selective Estrogen Receptor Modulators (SERMs)
• Biguanides
• Others

The market, based on end-users, is split into:

• Male
• Female

By distribution channel, the market is classified into:

• Hospital pharmacies
• Retail pharmacies
• Others

The regional markets for infertility drugs are:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market trends

With the rising incidence of infertility and miscarriages, the market for infertility drugs is witnessing robust growth. As the prevalence of various health conditions such as cystic fibrosis, menopausal disorders, testicular failure, ovarian cysts, diabetes, pelvic inflammatory disease (PID) and endometriosis increases, cases of infertility in males and females are increasing and driving the market growth. Additionally, increasing research activities to support the development of innovative and advanced infertility treatments are expected to propel the market. Rising healthcare expenditures for infertility treatment by governments are expected to provide lucrative growth opportunities for market expansion over the forecast period.

Main market players

Major market players include Merck KGaA, Abbott Laboratories, Mankind Pharma, Pfizer Inc., and Ferring Pharmaceuticals Inc., among others. The report covers market shares, capacities, plant rotations, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients stay at the forefront of their industries by providing comprehensive and actionable market data through its market reports unionized and customized, covering more than 15 major industry fields. The company’s extensive and ever-growing reporting database, which is constantly updated, includes reports from verticals such as Chemicals & Materials, Food & Beverages, Energy & Mining, technology and media, consumer goods, pharmaceuticals, agriculture and packaging.

EMR leverages its industry-leading technology and analytical tools, along with the expertise of its highly skilled team of 100+ analysts and 3,000+ consultants, to help its clients, ranging from Fortune 1000 companies to small and midsize companies. companies. businesses, easily grasp vast industry data and help them formulate market and business strategies, which ensure they stay ahead of the curve.

Media Contact

Company name: EMR Inc.
Contact Person:- Irene Garcia, Business Consultant
E-mail: [email protected]
Toll Free: USA +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Learn more about EMR Inc.’s Procurement Intelligence Services.

* At Expert Market Research, we always strive to give you the latest information. The figures in the article are only indicative and may differ from the actual report.

Comments are closed.